Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.48% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Meritage Homes
MTH
$4.75B
| $23.2M | 0.02% |
760,800
+594,600
| +358% | +$20.4M |
|
927
HCA Healthcare
HCA
$89.8B
| $23.2M | 0.02% |
157,100
-32,800
| -17% | -$4.4M |
|
|
LPT
928
DELISTED
Liberty Property Trust
LPT
| $23.1M | 0.02% |
385,400
+76,600
| +25% | +$4.39M |
|
|
KEM
929
DELISTED
KEMET Corporation
KEM
| $23M | 0.02% |
849,199
-360,100
| -30% | -$8.74M |
|
930
AvalonBay Communities
AVB
$25.7B
| $22.9M | 0.02% |
109,400
-482,914
| -82% | -$103M |
|
931
OR Royalties Inc
OR
$6.31B
| $22.9M | 0.02% |
2,362,600
+602,900
| +34% | +$5.5M |
|
932
Paysign
PAYS
$723M
| $22.9M | 0.02% |
2,255,119
+103,100
| +5% | +$1.08M |
|
933
Huron Consulting
HURN
$2.39B
| $22.8M | 0.02% |
331,658
+30,900
| +10% | +$2.01M |
|
934
Telefônica Brasil
VIV
$18.5B
| $22.8M | 0.02% |
1,591,200
+388,000
| +32% | +$5.18M |
|
935
Eagle Materials
EXP
$6.47B
| $22.8M | 0.02% |
251,300
+235,200
| +1,461% | +$21.5M |
|
936
iShares MSCI Brazil ETF
EWZ
$8.55B
| $22.7M | 0.02% |
479,400
+397,700
| +487% | +$17.4M |
|
937
Lindblad Expeditions
LIND
$2.24B
| $22.6M | 0.02% |
1,383,879
-15,500
| -1% | -$248K |
|
|
LX
938
LexinFintech Holdings
LX
$237M
| $22.6M | 0.02% |
1,627,461
-312,766
| -16% | -$3.59M |
|
939
Repligen
RGEN
$9.45B
| $22.6M | 0.02% |
244,332
+14,028
| +6% | +$1.18M |
|
|
PRMW
940
DELISTED
Primo Water Corporation
PRMW
| $22.5M | 0.02% |
1,647,385
-653,617
| -28% | -$8.52M |
|
941
Camden National
CAC
$990M
| $22.5M | 0.02% |
489,215
+415
| +0.1% | +$18.3K |
|
|
ISBC
942
DELISTED
Investors Bancorp, Inc.
ISBC
| $22.5M | 0.02% |
1,887,212
-59,399
| -3% | -$711K |
|
|
ONDK
943
DELISTED
On Deck Capital, Inc.
ONDK
| $22.4M | 0.02% |
5,405,229
-88,913
| -2% | -$357K |
|
944
Republic Services
RSG
$65.6B
| $22.3M | 0.02% |
248,961
+14,600
| +6% | +$1.28M |
|
|
PAMT
945
PAMT Corp
PAMT
$279M
| $22.2M | 0.02% |
1,540,296
-28,800
| -2% | -$419K |
|
946
FormFactor
FORM
$10.1B
| $22.2M | 0.02% |
855,669
+525,584
| +159% | +$11.9M |
|
947
Starwood Property Trust
STWD
$6.09B
| $22.2M | 0.02% |
892,622
+423,538
| +90% | +$10.4M |
|
948
Lithia Motors
LAD
$8.32B
| $22.2M | 0.02% |
150,900
+127,300
| +539% | +$19.1M |
|
949
Horizon Bancorp
HBNC
$1.05B
| $22.1M | 0.02% |
1,165,409
-1,200
| -0.1% | -$22K |
|
950
Expeditors International
EXPD
$24B
| $22.1M | 0.02% |
283,016
+62,300
| +28% | +$4.67M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.